T. Rowe Price Associates’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
1,468,393
-68,191
| -4% | -$474K | ﹤0.01% | 1106 |
|
|
2025
Q1 | $13M | Sell |
1,536,584
-48,543
| -3% | -$412K | ﹤0.01% | 1058 |
|
|
2024
Q4 | $22.2M | Sell |
1,585,127
-136,913
| -8% | -$1.92M | ﹤0.01% | 968 |
|
|
2024
Q3 | $39M | Buy |
1,722,040
+923,539
| +116% | +$20.9M | ﹤0.01% | 818 |
|
|
2024
Q2 | $16.2M | Buy |
798,501
+396,855
| +99% | +$8.03M | ﹤0.01% | 1007 |
|
|
2024
Q1 | $10M | Buy |
401,646
+124,809
| +45% | +$3.11M | ﹤0.01% | 1110 |
|
|
2023
Q4 | $5.01M | Sell |
276,837
-316,216
| -53% | -$5.72M | ﹤0.01% | 1206 |
|
|
2023
Q3 | $11.9M | Buy |
593,053
+295,768
| +99% | +$5.94M | ﹤0.01% | 1036 |
|
|
2023
Q2 | $7.59M | Sell |
297,285
-20,791
| -7% | -$531K | ﹤0.01% | 1110 |
|
|
2023
Q1 | $6.77M | Sell |
318,076
-20,657
| -6% | -$439K | ﹤0.01% | 1121 |
|
|
2022
Q4 | $10M | Sell |
338,733
-78,607
| -19% | -$2.33M | ﹤0.01% | 1053 |
|
|
2022
Q3 | $9.71M | Sell |
417,340
-3,921
| -0.9% | -$91.2K | ﹤0.01% | 1068 |
|
|
2022
Q2 | $7.07M | Sell |
421,261
-264,615
| -39% | -$4.44M | ﹤0.01% | 1372 |
|
|
2022
Q1 | $30.1M | Sell |
685,876
-110,138
| -14% | -$4.83M | ﹤0.01% | 1125 |
|
|
2021
Q4 | $48.5M | Buy |
+796,014
| New | +$48.5M | ﹤0.01% | 1018 |
|